NEU neuren pharmaceuticals limited

Ann: 2023 Results webinar, page-44

  1. 6,555 Posts.
    lightbulb Created with Sketch. 1857
    "To further clarify, although a CEO Jon is a medical person first and foremost."

    Guzz, I don't know whether that is quite correct. His first seven years at NEU were as Chief Financial Officer, before being appointed to the CEO role. Professionally, he is a qualified chartered account.
    He was with Richard Treagus at Acrux prior to Neren, where he was instrumental in the negotiation of a transformative deal with Eli-Lily and subsequently followed Treagus to Neuren in 2013.

    I suggest you read his bio.

    I would imagine the business side of things is his strength and primary focus. IMO, we are very lucky to have him as CEO.
    Last edited by What A Gas: 01/03/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.000(0.00%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.61 $12.68 $12.32 $7.219M 577.9K

Buyers (Bids)

No. Vol. Price($)
1 2968 $12.51
 

Sellers (Offers)

Price($) Vol. No.
$12.57 540 1
View Market Depth
Last trade - 16.16pm 25/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.